Prospeo
Hero Section BackgroundHero Section Background
MicroLumix Bioscience Technologies | GermPass

MicroLumix Bioscience Technologies | GermPass

Biotechnology ResearchFlag of USJacksonville, Florida, United States11-20 Employees

Company overview

HeadquartersJacksonville, Florida, United States
Phone number+11500000
Website
Keywords
Life Science, Biotech, Germ Killing
Founded2020
Employees11-20
Socials

Key Contacts at MicroLumix Bioscience Technologies | GermPass

Flag of US

Randy Moss

Director Of Infection Prevention

Flag of US

Chris Hickey

Chief Executive Officer | Biotechnology

Flag of US

Kelly Moss

Director Of Emerging Healthcare Threats

Flag of US

Daniel Denham

Director Of Electronics

MicroLumix Bioscience Technologies | GermPass Email Formats

MicroLumix Bioscience Technologies | GermPass uses 2 email formats. The most common is {first initial} (e.g., j@microlumix.com), used 85.7% of the time.

FormatExamplePercentage
{first initial}
j@microlumix.com
85.7%
{first name}
john@microlumix.com
14.3%

About MicroLumix Bioscience Technologies | GermPass

In response to seeing our technology for the first time, a member of the Mayo Clinic team told us, “As a citizen on this planet, I want to see this everywhere.” MicroLumix patented automated disinfection technology, GermPass, has been independently lab tested and shown to kill greater than 99.999% of germs (> 5-log reduction) within a few seconds after virtually every single touch. This proprietary technology is a game-changer for preventing unnecessary deaths and illnesses in healthcare and across the public and private sectors. The MicroLumix mission is to prevent needless morbidity and mortality, along with the significant financial consequences, caused by contaminated high-volume touchpoints. GermPass integrates with existing high-volume touchpoints such as elevators, doors, and restrooms, utilizing proprietary patented UVC-enabled technology to deliver a fatal blow to pathogens within a few seconds after every human interaction. Independently tested by world-renowned environmental microbiologist Dr Charles Gerba’s team at the University of Arizona, GermPass was tested against a panel of 14 potentially lethal pathogens including spores, fungi, viruses, and bacteria. Their analysis revealed that GermPass achieved greater than 99.99931% inactivation of the germs within 7 seconds. MicroLumix is an industry pioneer, functioning at the forefront of public safety research and technological innovation. Our groundbreaking research, directly tying contaminated HVTs to infectious disease transmission, is irrefutable and will ultimately lead to saving millions of lives each year. In support of our stated mission, MicroLumix is calling on leadership in both the public and private sectors; healthcare, travel, tourism, entertainment, and industry, to take massive and immediate action to decontaminate public surfaces and prevent the pain and suffering caused through the neglectful avoidance of HVT sanitization. Together, we can make a difference!

$

MicroLumix Bioscience Technologies | GermPass revenue & valuation

Annual revenue$1,283,325
Revenue per employee$86,000
Estimated valuation?$4,200,000
Total fundingNo funding

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry
Director
Vice President

Employees by Department

MicroLumix Bioscience Technologies | GermPass has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

MicroLumix Bioscience Technologies | GermPass has never raised funding before.

MicroLumix Bioscience Technologies | GermPass Tech Stack

Discover the technologies and tools that power MicroLumix Bioscience Technologies | GermPass's digital infrastructure, from frameworks to analytics platforms.

Underscore.js

Underscore.js

JavaScript libraries

Slick

Slick

JavaScript libraries

Vimeo

Vimeo

Video players

Animate.css

Animate.css

UI frameworks

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

jQuery

JavaScript libraries

PHP

PHP

Programming languages

Bluehost

Bluehost

Hosting

WordPress

WordPress

Blogs

Google Analytics

Google Analytics

Analytics

Frequently asked questions

MicroLumix Bioscience Technologies | GermPass is located in Jacksonville, Florida, US.
You can reach MicroLumix Bioscience Technologies | GermPass at +11500000.
MicroLumix Bioscience Technologies | GermPass was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.
MicroLumix Bioscience Technologies | GermPass has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles